389 related articles for article (PubMed ID: 19471890)
1. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
Cho CW; Choi JS; Yang KH; Shin SC
Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
[TBL] [Abstract][Full Text] [Related]
2. Development and biopharmaceutical evaluation of quinupramine-EVA matrix containing penetration enhancer for the enhanced transdermal absorption in rats.
Shin SC; Kim J; Kim WJ; Kim SJ; Cho CW
Pharm Dev Technol; 2007; 12(5):429-36. PubMed ID: 17963142
[TBL] [Abstract][Full Text] [Related]
3. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats.
Shin SC; Choi JS
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):14-9. PubMed ID: 16005195
[TBL] [Abstract][Full Text] [Related]
4. Enhanced transdermal delivery of pranoprofen from the bioadhesive gels.
Shin SC; Cho CW
Arch Pharm Res; 2006 Oct; 29(10):928-33. PubMed ID: 17121190
[TBL] [Abstract][Full Text] [Related]
5. Enhanced transdermal delivery of loratadine from the EVA matrix.
Cho CW; Choi JS; Kim SJ; Shin SC
Drug Deliv; 2009 May; 16(4):230-5. PubMed ID: 19514983
[TBL] [Abstract][Full Text] [Related]
6. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
Cho CW; Choi JS; Yang KH; Shin SC
Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of pranoprofen from the ethylene-vinyl acetate matrix using plasticizer.
Cho CW; Choi JS; Shin SC
Drug Dev Ind Pharm; 2007 Jul; 33(7):747-53. PubMed ID: 17654023
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
9. Enhanced bioavailability of atenolol by transdermal administration of the ethylene-vinyl acetate matrix in rabbits.
Shin SC; Choi JS
Eur J Pharm Biopharm; 2003 Nov; 56(3):439-43. PubMed ID: 14602188
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of formulated tenoxicam transdermal delivery systems.
Kim T; Kang E; Chun I; Gwak H
J Pharm Pharmacol; 2008 Jan; 60(1):135-8. PubMed ID: 18088513
[TBL] [Abstract][Full Text] [Related]
11. Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix.
Cho CW; Shin SC
Int J Pharm; 2004 Dec; 287(1-2):67-71. PubMed ID: 15541913
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of pranoprofen gel for percutaneous administration.
Choi JS; Shin SC
Drug Dev Ind Pharm; 2007 Jan; 33(1):19-26. PubMed ID: 17192247
[TBL] [Abstract][Full Text] [Related]
13. Enhanced transdermal drug delivery of zaltoprofen using a novel formulation.
Baek JS; Lim JH; Kang JS; Shin SC; Jung SH; Cho CW
Int J Pharm; 2013 Sep; 453(2):358-62. PubMed ID: 23747435
[TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of limonene-based membrane-moderated transdermal therapeutic system of nimodipine.
Krishnaiah YS; Bhaskar P; Satyanarayana V
Drug Deliv; 2004; 11(1):1-9. PubMed ID: 15168785
[TBL] [Abstract][Full Text] [Related]
15. Enhanced bioavailability of triprolidine from the transdermal TPX matrix system in rabbits.
Shin SC; Choi JS
Int J Pharm; 2002 Mar; 234(1-2):67-73. PubMed ID: 11839438
[TBL] [Abstract][Full Text] [Related]
16. Effect of carvone on the permeation of nimodipine from a membrane-moderated transdermal therapeutic system.
Krishnaiah YS; Bhaskar P; Satyanarayana V
Pharmazie; 2003 Aug; 58(8):559-63. PubMed ID: 12967033
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.
Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Parra A; Calpena A; Garcia ML
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):261-70. PubMed ID: 25681744
[TBL] [Abstract][Full Text] [Related]
18. Biopharmaceutical profile of hydrogels containing pranoprofen-loaded PLGA nanoparticles for skin administration: In vitro, ex vivo and in vivo characterization.
Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Garduño ML; Garcia ML; Calpena AC
Int J Pharm; 2016 Mar; 501(1-2):350-61. PubMed ID: 26844786
[TBL] [Abstract][Full Text] [Related]
19. Development of a drug-in-adhesive patch combining ion pair and chemical enhancer strategy for transdermal delivery of zaltoprofen: pharmacokinetic, pharmacodynamic and in vitro/in vivo correlation evaluation.
Cui H; Quan P; Zhou Z; Fang L
Drug Deliv; 2016 Nov; 23(9):3461-3470. PubMed ID: 27257038
[TBL] [Abstract][Full Text] [Related]
20. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
Singh S; Gajra B; Rawat M; Muthu MS
Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
